TRANSCEND-T2D-1 TRANSCEND-T2D-1, a randomized, double-blind, placebo-controlled phase 3 study, assessed the safety and efficacy of retatrutide monotherapy in adults with recent-onset type 2 diabetes who had inadequate glycemic management despite diet and exercise alone
Our experienced medical team creates individualized plans tailored to support your medical weight loss journey in a safe, sustainable manner
CrossRef Longitudinal performance of vibration controlled transient elastography in pediatric metabolic dysfunction associated steatotic liver disease Naima DiopWest, Nicholas Denson, Ana Catalina ArceClachar, Julie Bonn, Kristin Bramlage, Lisa Leesman, Rashmi D
Ozempic and similar weight loss drugs may impact medical imaging results Ozempic and similar weight loss drugs may impact PET-CT imaging results, according to new research
Staying hydrated is crucial, especially as dehydration can exacerbate side effects including headaches
Lower risks for AF associated with GLP-1RA were consistently observed in subgroups by baseline age, sex, race, BMI, and HbA1c